Eversept Partners’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,272,102
Closed -$15.8M 72
2024
Q4
$15.8M Sell
1,272,102
-454,252
-26% -$5.58M 1.41% 15
2024
Q3
$20M Buy
1,726,354
+397,072
+30% +$4.58M 1.37% 18
2024
Q2
$14.1M Buy
1,329,282
+12,813
+1% +$142K 0.97% 24
2024
Q1
$15.7M Buy
+1,316,469
New +$15.9M 1.05% 21
2020
Q4
Sell
-324,951
Closed -$4.82M 70
2020
Q3
$4.82M Buy
+324,951
New +$5.19M 1.07% 25
2019
Q1
Sell
-55,000
Closed -$1.51M 64
2018
Q4
$1.51M Buy
+55,000
New +$1.78M 0.82% 24

Other funds holding VTRS

Eversept Partners's VTRS Position: Q1 2025 in Review

Eversept Partners sold out of Viatris (VTRS) in Q1 2025, closing a stake of 1,272,102 shares — an estimated $15.8M sold.

Eversept Partners first reported a position in VTRS in Q4 2018 and held it in 6 quarters. The position peaked at $20M in Q3 2024. 1,010 funds tracked by Wall St. Rank hold VTRS as of Q1 2025.

  • Eversept Partners reported no remaining Viatris position as of Q1 2025 after selling out during the quarter.
  • Eversept Partners sold 1,272,102 Viatris shares in Q1 2025, an estimated $15.8M.
  • Eversept Partners first reported a position in Viatris in Q4 2018 and held it in 6 quarters.
  • Eversept Partners's Viatris position peaked at $20M in Q3 2024.
  • 1,010 funds tracked by Wall St. Rank held Viatris as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.